These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25058872)

  • 1. Structural characterization of the C3 domain of cardiac myosin binding protein C and its hypertrophic cardiomyopathy-related R502W mutant.
    Zhang XL; De S; McIntosh LP; Paetzel M
    Biochemistry; 2014 Aug; 53(32):5332-42. PubMed ID: 25058872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HCM-linked W792R mutation in cardiac myosin-binding protein C reduces C6 FnIII domain stability.
    Smelter DF; de Lange WJ; Cai W; Ge Y; Ralphe JC
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1179-H1191. PubMed ID: 29451820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of the binding site of the C-terminal domain of cardiac myosin-binding protein-C on the myosin rod.
    Flashman E; Watkins H; Redwood C
    Biochem J; 2007 Jan; 401(1):97-102. PubMed ID: 16918501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities.
    Schlossarek S; Mearini G; Carrier L
    J Mol Cell Cardiol; 2011 Apr; 50(4):613-20. PubMed ID: 21291890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.
    Kuster DW; Govindan S; Springer TI; Martin JL; Finley NL; Sadayappan S
    J Biol Chem; 2015 Feb; 290(9):5855-67. PubMed ID: 25583989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and spectroscopic studies of a familial hypertrophic cardiomyopathy mutation in Motif X of cardiac myosin binding protein-C.
    Brown LJ; Singh L; Sale KL; Yu B; Trent R; Fajer PG; Hambly BD
    Eur Biophys J; 2002 Sep; 31(5):400-8. PubMed ID: 12202917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The A31P missense mutation in cardiac myosin binding protein C alters protein structure but does not cause haploinsufficiency.
    van Dijk SJ; Bezold Kooiker K; Mazzalupo S; Yang Y; Kostyukova AS; Mustacich DJ; Hoye ER; Stern JA; Kittleson MD; Harris SP
    Arch Biochem Biophys; 2016 Jul; 601():133-40. PubMed ID: 26777460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy.
    Gajendrarao P; Krishnamoorthy N; Selvaraj S; Girolami F; Cecchi F; Olivotto I; Yacoub M
    J Cardiovasc Transl Res; 2015 Jun; 8(4):232-43. PubMed ID: 25971843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of disease causing mutations in domain C1 of cMyBP-C.
    Gajendrarao P; Krishnamoorthy N; Kassem HSh; Moharem-Elgamal S; Cecchi F; Olivotto I; Yacoub MH
    PLoS One; 2013; 8(3):e59206. PubMed ID: 23527136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo definition of cardiac myosin-binding protein C's critical interactions with myosin.
    Bhuiyan MS; McLendon P; James J; Osinska H; Gulick J; Bhandary B; Lorenz JN; Robbins J
    Pflugers Arch; 2016 Oct; 468(10):1685-95. PubMed ID: 27568194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy.
    Suay-Corredera C; Pricolo MR; Velázquez-Carreras D; Pathak D; Nandwani N; Pimenta-Lopes C; Sánchez-Ortiz D; Urrutia-Irazabal I; Vilches S; Dominguez F; Frisso G; Monserrat L; García-Pavía P; de Sancho D; Spudich JA; Ruppel KM; Herrero-Galán E; Alegre-Cebollada J
    ACS Nano; 2021 Jun; 15(6):10203-10216. PubMed ID: 34060810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac myosin binding protein C: its role in physiology and disease.
    Flashman E; Redwood C; Moolman-Smook J; Watkins H
    Circ Res; 2004 May; 94(10):1279-89. PubMed ID: 15166115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy.
    Meurs KM; Norgard MM; Ederer MM; Hendrix KP; Kittleson MD
    Genomics; 2007 Aug; 90(2):261-4. PubMed ID: 17521870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy.
    Oakley CE; Hambly BD; Curmi PM; Brown LJ
    Cell Res; 2004 Apr; 14(2):95-110. PubMed ID: 15115610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically Linked Mutations in the Central Domains of Cardiac Myosin-Binding Protein C with Distinct Phenotypes Show Differential Structural Effects.
    Nadvi NA; Michie KA; Kwan AH; Guss JM; Trewhella J
    Structure; 2016 Jan; 24(1):105-115. PubMed ID: 26688216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C.
    Gruen M; Gautel M
    J Mol Biol; 1999 Feb; 286(3):933-49. PubMed ID: 10024460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament.
    Harris SP; Lyons RG; Bezold KL
    Circ Res; 2011 Mar; 108(6):751-64. PubMed ID: 21415409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of disease-causing mutations on inter-domain interactions in cMyBP-C: a steered molecular dynamics study.
    Krishnamoorthy N; Gajendrarao P; Olivotto I; Yacoub M
    J Biomol Struct Dyn; 2017 Jul; 35(9):1916-1922. PubMed ID: 27267291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.